Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests
Go back to Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests| (NASDAQ: FLGT) | Delayed: 17.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.84 | 52 Week High | $10.90 | |||
| Open | $17.84 | 52 Week Low | $7.59 | |||
| Day High | $17.84 | P/E | N/A | |||
| Day Low | $17.84 | EPS | $0.00 | |||
| Volume | 9 | |||||

